Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account
Biokit USA, Inc. — Predicate Candidate Screening
16 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.
67 daysmedian FDA review time
256 days90th percentile
16clearances measured
| K-number | Device | Applicant | Decided | Review days | Recalls (K-match) |
|---|---|---|---|---|---|
| K913467 | TOXOGEN | Biokit USA, Inc. | 1993-01-11 | 525 | 0 |
| K910541 | BIOKIT RPR | Biokit USA, Inc. | 1991-10-18 | 256 | 0 |
| K904310 | RHEUMAGEN RF T-CONTROL | Biokit USA, Inc. | 1991-05-31 | 254 | 0 |
| K910539 | RHEUMAJET RF | Biokit USA, Inc. | 1991-04-05 | 67 | 0 |
| K910686 | RHEUMAJET CRP | Biokit USA, Inc. | 1991-03-19 | 28 | 0 |
| K904311 | RHEUMAGEN ASO T-CONTROL | Biokit USA, Inc. | 1991-01-25 | 128 | 0 |
| K904312 | RHEUMAGEN CRP T-CONTROL | Biokit USA, Inc. | 1990-10-01 | 12 | 0 |
| K896433 | MODIFIED RUBAGEN | Biokit USA, Inc. | 1989-11-29 | 20 | 0 |
| K896271 | QUANTEX RF PLUS (LATEX, BUFFER STANDARD, CONTROL) | Biokit USA, Inc. | 1989-11-08 | 9 | 0 |
| K896272 | QUANTEX CRP PLUS (LATEX, BUFFER, STANDARD, CONTROL | Biokit USA, Inc. | 1989-11-08 | 9 | 0 |
| K894486 | QUANTEX ASO PLUS (LATEX,BUFFER STANDARD,CONTROL) | Biokit USA, Inc. | 1989-10-24 | 98 | 0 |
| K893755 | RUBAGEN | Biokit USA, Inc. | 1989-08-21 | 94 | 0 |
| K874678 | I.M.N. LATEX | Biokit USA, Inc. | 1987-12-14 | 31 | 0 |
| K854991 | REUMAGEN ASL | Biokit USA, Inc. | 1986-04-18 | 127 | 0 |
| K843741 | RPR TEST REDITEST | Biokit USA, Inc. | 1984-10-25 | 30 | 0 |
| K842256 | AS LATEX PLUS | Biokit USA, Inc. | 1984-06-19 | 12 | 0 |
Methodology
Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.
Prepared with Atlas
Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda